Evogene to Hold Virtual Investor & Analyst Days

Rhea-AI Summary

Evogene Ltd. (NASDAQ: EVGN) announced plans to host virtual investor and analyst days on April 19 and April 21, 2021, in Hebrew and English, respectively. The events will feature key presentations from CEO Ofer Haviv and the CEOs of Evogene’s subsidiaries, including Biomica and Lavie Bio, followed by Q&A sessions. The Hebrew event is scheduled for April 19 at 4 PM IST, while the English event is set for April 21 at the same time. Registration links for both webinars are provided, emphasizing Evogene's focus on computational biology for product discovery in human health and agriculture.

Positive

• Scheduled virtual investor and analyst days, enhancing transparency and engagement with stakeholders.
• Key presentations from multiple subsidiary CEOs, showcasing Evogene's diverse business operations.

Negative

• None.

REHOVOT, Israel, April 7, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars.

The meetings will feature key-note presentations from Evogene's CEO, Ofer Haviv, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and Lavie Bio, followed by a question and answer session.

• The Hebrew language event will be held on Monday, April 19, 2021 at 4pm IST or 9am ET. To register for this event, please visit the link:
  https://zoom.us/webinar/register/WN_MpdKOdKeTvqyR6LDbpJlCQ 
• The English language event will be held on Wednesday, April 21, 2021 at 4pm IST or 9am ET. To register for this event, please visit the link:
  https://zoom.us/webinar/register/WN_k8B2V0g_R9e1xYv5WIpt6A 

 

Questions to the speakers may be sent in advance of the event via the registration link or to ir@evogene.com or may be sent via the Question and Answer link in the zoom webinar during the event.

About Evogene Ltd.:

Evogene (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform.  The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements.  Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd.

 

Evogene Investor Contact:	US Investor Relations:
Rivka Neufeld / Aviva Banczewski	Joseph Green
Investor Relations	Edison Group
E: IR@evogene.com	E: jgreen@edisongroup.com
T: +972-8-931-1900	T: +1 646-653-7030
	Laine Yonker
	Edison Group
	E: lyonker@edisongroup.com
	T: +1 646-653-7035

View original content:http://www.prnewswire.com/news-releases/evogene-to-hold-virtual-investor--analyst-days-301263905.html

SOURCE Evogene

FAQ

When are Evogene's virtual investor and analyst days scheduled?

The Hebrew event is on April 19, 2021, at 4 PM IST, and the English event is on April 21, 2021, at 4 PM IST.

Who will present at Evogene's investor days?

Presentations will be made by Evogene's CEO Ofer Haviv and the CEOs of its subsidiaries such as Biomica and Lavie Bio.

How can I register for Evogene's virtual investor day?

Registration links for both the Hebrew and English events are provided in the press release.

What is the focus of Evogene's business?

Evogene focuses on computational biology for product discovery in human health and agriculture.